Haikun is a final year PhD student at the Molecular Imaging and Theranostics laboratory and the recently established Centre for Cardiometabolic mRNA Therapies within the Baker Department of Cardiometabolic Health, The University of Melbourne, Australia. His primary research focus is on the development of innovative mRNA delivery systems aimed at advancing the treatment of cardiovascular diseases. This work involves exploring novel strategies to enhance the efficiency and specificity of mRNA-based therapeutics, with the ultimate goal of improving patient outcomes.

Another crucial component of Haikun’s work involves developing imaging contrast agents for the diagnosis of cardiovascular diseases and designing theranostic systems for imaging-guided drug delivery to the vasculature. This aspect of his research seeks to improve the accuracy and reliability of diagnostic imaging techniques, enabling earlier detection and more precise monitoring of cardiovascular conditions and treatments. Through his research, he is committed to bridging the gap between cutting-edge scientific innovation and clinical application, contributing to the development of transformative solutions for cardiovascular health.